NM_080701.4:c.266G>A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_080701.4(TREX2):c.266G>A(p.Arg89Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,207,809 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 45 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080701.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000971 AC: 11AN: 113241Hom.: 0 Cov.: 24 AF XY: 0.0000282 AC XY: 1AN XY: 35403
GnomAD3 exomes AF: 0.000131 AC: 22AN: 168345Hom.: 0 AF XY: 0.000103 AC XY: 6AN XY: 58039
GnomAD4 exome AF: 0.000126 AC: 138AN: 1094568Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 44AN XY: 360882
GnomAD4 genome AF: 0.0000971 AC: 11AN: 113241Hom.: 0 Cov.: 24 AF XY: 0.0000282 AC XY: 1AN XY: 35403
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.266G>A (p.R89Q) alteration is located in exon 2 (coding exon 1) of the TREX2 gene. This alteration results from a G to A substitution at nucleotide position 266, causing the arginine (R) at amino acid position 89 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at